Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,648
Closed -$273K 174
2022
Q4
$273K Sell
3,648
-1,162
-24% -$82.8K 0.15% 138
2022
Q3
$310K Hold
4,810
0.17% 117
2022
Q2
$333K Hold
4,810
0.24% 98
2022
Q1
$370K Sell
4,810
-986
-17% -$70.9K 0.19% 122
2021
Q4
$444K Buy
+5,796
New +$426K 0.22% 108

Other funds holding HOLX

TriaGen Wealth Management's HOLX Position: Q1 2023 in Review

TriaGen Wealth Management sold out of Hologic (HOLX) in Q1 2023, closing a stake of 3,648 shares — an estimated $273K sold.

TriaGen Wealth Management first reported a position in HOLX in Q4 2021 and held it in 5 quarters. The position peaked at $444K in Q4 2021. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • TriaGen Wealth Management reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • TriaGen Wealth Management sold 3,648 Hologic shares in Q1 2023, an estimated $273K.
  • TriaGen Wealth Management first reported a position in Hologic in Q4 2021 and held it in 5 quarters.
  • TriaGen Wealth Management's Hologic position peaked at $444K in Q4 2021.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on TriaGen Wealth Management's 13F filing for Q1 2023, filed 24 Apr 2023.